Dr. Zachary Roberts, currently EVP of R&D and CMO, will become President and CEO on July 1, 2026. Outgoing CEO Dr. David Chang will transition to a non-employee director role on the Board. Dr. Roberts will receive an annual base salary of $680,000 and a 60% target performance cash incentive. The compensation package includes an option to purchase 476,190 shares and 134,530 restricted stock units (RSUs).